Patent Eligibility and Engineered Natural Products: Overcoming 101 Challenges, Leveraging Options for IP Protection

Ms. Meyers focuses on patent litigation, specifically Abbreviated New Drug Application (ANDA) matters at the district court level and in appeals to the U.S. Court of Appeals for the Federal Circuit, as well as patent prosecution and client counseling. She has experience representing pharmaceutical patent holders in ANDA and 505(b)(2) application litigations arising under the Hatch-Waxman Act. She has technical experience in the biomedical field, including technologies such as prosthetic limbs and orthotic devices.

Mr. Smyth practices intellectual property litigation in a wide variety of areas, with a particular focus on cases involving pharmaceutical and life sciences technologies. He applies a thorough and creative approach to disputes in U.S. district courts, appeals at the U.S. Federal Circuit of Appeals, and arbitration proceedings, which is often where clients’ most important assets are at stake. Mr. Smyth litigates complex disputes involving patents, copyrights, and allegations of trade secret misappropriation in cases involving technologies across fields, including electrical, mechanical, and computer inventions. He is involved in all aspects of U.S. district court litigation, including pre-litigation activity and analysis, written discovery, taking and defending depositions, working with experts, and drafting motions and legal briefs. Mr. Smyth’s trial experience includes participating in jury trials in the Northern District of California, virtual trials in American Arbitration Association arbitrations, and appeals before the Federal Circuit.